Ganding, Michelle T.

HRN: 21-95-51  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
CEFUROXIME 1.5GM (VIAL)
10/13/2022
10/20/2022
IV
1.5gm
Q8h
UTI

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Non-compliant To Guidelines